ResearcherTokyo Metropolitan Komagome HospitalActive in the last 2 years
Terumi Kamisawa
Matched on ORCID iD 0000-0002-2237-2767; OpenAlex author ID A5089230325. Sources: OpenAlex.
Their work
- Papers
- 13 (first author 5, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 47
2011: 2 papers · 2012: none · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 2 papers · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 2 papers
Papers 13
- Association between autoimmune pancreatitis and pancreatic cancer: a case after long-term steroid therapy. Last author DOI 10.1007/s12328-026-02398-x↗
- Accelerated Pancreatic Volume Loss as a Potential Pre-Diagnostic Imaging Biomarker for Pancreatic Cancer Risk Enrichment: An AI-Assisted Volumetric Study. Co-author DOI 10.3390/cancers18183062↗
- Concordance of the histological diagnosis of type 1 autoimmune pancreatitis and its distinction from pancreatic ductal adenocarcinoma with endoscopic ultrasoun… First author DOI 10.1007/s00428-021-03236-w↗
- Focal pancreatic parenchyma atrophy is a harbinger of pancreatic cancer and a clue to the intraductal spreading subtype. Last author DOI 10.1016/j.pan.2022.10.003↗
- Pancreatic cancer in patients with autoimmune pancreatitis: A scoping review. Co-author DOI 10.1016/j.pan.2021.03.007↗
- Proposal for Endoscopic Ultrasonography Classification for Small Pancreatic Cancer. Co-author DOI 10.3390/diagnostics9010015↗
- Acute obstructive suppurative pancreatic ductitis (AOSPD) in pancreatic cancer treated by nasopancreatic drainage. Co-author DOI 10.1007/s12328-018-0830-z↗
- Early Diagnosis to Improve the Poor Prognosis of Pancreatic Cancer. First author DOI 10.3390/cancers10020048↗
- Pancreatic cancer. Co-author DOI 10.1016/s0140-6736(16)00141-0↗
- A Phase I Study of S-1 and Gemcitabine with Concurrent Radiotherapy in Patients with Non-Metastatic Advanced Pancreatic Cancer. Co-author PMID 26902051↗
- Pancreatic cancer causing acute pancreatitis: a comparative study with cancer patients without pancreatitis and pancreatitis patients without cancer. First author DOI 10.1007/s00534-013-0598-y↗
- Pancreatic cancer as the fourth cancer in a patient with Peutz-Jeghers syndrome and a history of familial pancreatic cancer. First author DOI 10.1097/mpa.0b013e3181ea6147↗
- Incidence of and risk factors for developing pancreatic cancer in patients with chronic pancreatitis. First author PMID 21661440↗
Closest collaborators
The 25 strongest of 47 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kazuro Chiba · 7 shared papers, 2013–2026 · strength 1.01
- Paper Association between autoimmune pancreatitis and pancreatic cancer: a case after long-term steroid therapy. DOI 10.1007/s12328-026-02398-x↗
- Paper Accelerated Pancreatic Volume Loss as a Potential Pre-Diagnostic Imaging Biomarker for Pancreatic Cancer Risk Enrichmen… DOI 10.3390/cancers18183062↗
- Paper Focal pancreatic parenchyma atrophy is a harbinger of pancreatic cancer and a clue to the intraductal spreading subtype. DOI 10.1016/j.pan.2022.10.003↗
- Masataka Kikuyama · 6 shared papers, 2018–2026 · strength 0.98
- Paper Association between autoimmune pancreatitis and pancreatic cancer: a case after long-term steroid therapy. DOI 10.1007/s12328-026-02398-x↗
- Paper Accelerated Pancreatic Volume Loss as a Potential Pre-Diagnostic Imaging Biomarker for Pancreatic Cancer Risk Enrichmen… DOI 10.3390/cancers18183062↗
- Paper Focal pancreatic parenchyma atrophy is a harbinger of pancreatic cancer and a clue to the intraductal spreading subtype. DOI 10.1016/j.pan.2022.10.003↗
- Jun Nakahodo · 4 shared papers, 2019–2026 · strength 0.79
- Paper Association between autoimmune pancreatitis and pancreatic cancer: a case after long-term steroid therapy. DOI 10.1007/s12328-026-02398-x↗
- Paper Accelerated Pancreatic Volume Loss as a Potential Pre-Diagnostic Imaging Biomarker for Pancreatic Cancer Risk Enrichmen… DOI 10.3390/cancers18183062↗
- Paper Focal pancreatic parenchyma atrophy is a harbinger of pancreatic cancer and a clue to the intraductal spreading subtype. DOI 10.1016/j.pan.2022.10.003↗
- Ryogo Minami · 2 shared papers, 2026 · strength 0.53
- Paper Association between autoimmune pancreatitis and pancreatic cancer: a case after long-term steroid therapy. DOI 10.1007/s12328-026-02398-x↗
- Paper Accelerated Pancreatic Volume Loss as a Potential Pre-Diagnostic Imaging Biomarker for Pancreatic Cancer Risk Enrichmen… DOI 10.3390/cancers18183062↗
- Masanao Kurata · 4 shared papers, 2011–2026 · strength 0.35
- Paper Accelerated Pancreatic Volume Loss as a Potential Pre-Diagnostic Imaging Biomarker for Pancreatic Cancer Risk Enrichmen… DOI 10.3390/cancers18183062↗
- Paper A Phase I Study of S-1 and Gemcitabine with Concurrent Radiotherapy in Patients with Non-Metastatic Advanced Pancreatic… PMID 26902051↗
- Paper Pancreatic cancer as the fourth cancer in a patient with Peutz-Jeghers syndrome and a history of familial pancreatic ca… DOI 10.1097/mpa.0b013e3181ea6147↗
- Sawako Kuruma · 4 shared papers, 2013–2019 · strength 0.31
- Paper Acute obstructive suppurative pancreatic ductitis (AOSPD) in pancreatic cancer treated by nasopancreatic drainage. DOI 10.1007/s12328-018-0830-z↗
- Paper Early Diagnosis to Improve the Poor Prognosis of Pancreatic Cancer. DOI 10.3390/cancers10020048↗
- Paper Proposal for Endoscopic Ultrasonography Classification for Small Pancreatic Cancer. DOI 10.3390/diagnostics9010015↗
- Masakazu Toi · 1 shared paper, 2026 · strength 0.24
- Kensuke Kubota · 2 shared papers, 2021–2022 · strength 0.21
- Itaru Naitoh · 2 shared papers, 2021–2022 · strength 0.21
- Tsukasa Ikeura · 2 shared papers, 2021–2022 · strength 0.21
- Kazuichi Okazaki · 2 shared papers, 2021–2022 · strength 0.21
- Shuzo Terada · 2 shared papers, 2018–2019 · strength 0.18
- Shinya Kawaguchi · 2 shared papers, 2018–2019 · strength 0.18
- Goro Honda · 2 shared papers, 2013–2019 · strength 0.12
- Petr Dítě DrSc · 1 shared paper, 2021 · strength 0.11
- Tomáš Hucl · 1 shared paper, 2021 · strength 0.11
- Miroslav Vujasinović · 1 shared paper, 2021 · strength 0.11
- Peter Mačinga · 1 shared paper, 2021 · strength 0.11
- Marco Del Chiaro · 1 shared paper, 2021 · strength 0.11
- Suresh T. Chari · 1 shared paper, 2021 · strength 0.11
- Matthias J. Löhr · 1 shared paper, 2021 · strength 0.11
- Raffaele Pezzilli · 1 shared paper, 2021 · strength 0.11
- Ryoko Shimizuguchi · 1 shared paper, 2018 · strength 0.11
- Yoshiki Naito · 1 shared paper, 2022 · strength 0.10
- Kenji Notohara · 1 shared paper, 2022 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.